# Retracted: Distinct Molecular Subtypes of Diffuse Large B Cell Lymphoma Patients Treated with Rituximab-CHOP Are Associated with Different Clinical Outcomes and Molecular Mechanisms

**Authors:** BioMed Research International

PMC · DOI: 10.1155/2024/9846925 · BioMed Research International · 2024-03-20

## Full-text entities

- **Diseases:** Diffuse Large B Cell Lymphoma (MESH:D016403)
- **Chemicals:** Rituximab (MESH:D000069283), CHOP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10977124/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10977124/full.md

---
Source: https://tomesphere.com/paper/PMC10977124